Zimmer Biomet Announces Successful Completion of World’s First Robotic-Assisted Shoulder Replacement Surgery with ROSA® Shoulder System

(WARSAW, Ind.,) April 25, 2024 – Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the successful completion of the world’s first robotic-assisted shoulder replacement surgery using its ROSA^® Shoulder System. The surgery was performed at Mayo Clinic by John W. Sperling, MD, MBA, Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota, and a key contributor to the ROSA Shoulder development team.

“The debut of ROSA Shoulder marks an incredible milestone for Zimmer Biomet and we are honored to have the first patient case performed by Dr. Sperling, who is widely recognized for his practiced expertise in shoulder reconstruction,” said Ivan Tornos, President and Chief Executive Officer at Zimmer Biomet. “ROSA Shoulder reinforces our dedicated pursuit to deliver first-to-world innovative solutions that help surgeons perform complex orthopedic procedures.”

“Adding robotic surgical assistance to shoulder replacement surgery has the potential to transform intra-operative and post-operative outcomes, while improving the overall patient experience,” said Dr. Sperling.

ROSA Shoulder received U.S. FDA 510(k) clearance in February of 2024, and is designed to give surgeons the flexibility to execute a total shoulder replacement using anatomic or reverse techniques and to enable precise placement.¹ Like all ROSA Robotics applications, ROSA Shoulder is designed to support data-informed physician decision-making based on a patient’s unique anatomy. Pre-operatively, ROSA Shoulder integrates with the newly released Signature™ ONE 2.0 Surgical Planning System, which uses a 3-D image-based approach for visualization of humeral and glenoid anatomy, and surgical planning. During the surgery, the platform provides surgeons with real-time, intra-operative data to help control, execute and validate personalized plans for accurate glenoid and humeral implant placement.¹ The goal is to reduce risk of complications for the patient, enhance the clinical outcome and improve patient satisfaction.^2,3,4,5

ROSA Shoulder bolsters ZBEdge™ Dynamic Intelligence™ solutions, which leverage cutting-edge technology paired with our robust portfolio of shoulder implant systems to offer patients a highly personalized experience.

To learn more about ROSA Shoulder, visit zimmerbiomet.com/ROSAShoulder.

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.